Developed in conjunction with

September, 2015
SOM Biotech announces that its product development partnership...
September, 2015
SOM Biotech has just filed a new patent application for the treatment of Psoriasis, chronic and autoimmune disease that...

September, 2012

A recent Thomson Reuters report indicates that drug repositioning is expected to generate up to $20Billion in annual sales during 2012, thus opening up a new source of revenue to large, medium and small Pharma companies.